Result Filters
Immunoprophylaxis with palivizumab, a humanized respiratory syncytial virus monoclonal antibody, for prevention of respiratory syncytial virus infection in high risk infants: a consensus opinion.
- 1
- Department of Pediatrics, New England Medical Center, Tufts University School of Medicine, Boston, Mass 02111, USA. cmeissner@es.nemc.org
Publication types
MeSH terms
Substances
Full Text Sources
Other Literature Sources
Medical
Miscellaneous